Home > Insider Trading > Filing (0001144204-15-017760)

Filing Details

Accession Number:: 0001144204-15-017760
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-23 16:06:11
Reporting Period:: 2015-03-19

Filing Date:: 2015-03-23
Accepted Time:: 2015-03-23 16:06:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434868	Esperion Therapeutics Inc.	ESPR	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1253886	G Patrick Enright	C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-03-19	283,601	$110.01	1,122,609	No	4	S	Indirect	By LVP
Common Stock	Disposition	2015-03-19	3,353	$111.06	1,119,256	No	4	S	Indirect	By LVP
Common Stock	Disposition	2015-03-19	194,988	$113.92	924,268	No	4	S	Indirect	By LVP
Common Stock	Disposition	2015-03-19	2,156	$114.15	922,112	No	4	S	Indirect	By LVP
Common Stock	Disposition	2015-03-19	6,077	$116.05	916,035	No	4	S	Indirect	By LVP
Common Stock	Disposition	2015-03-19	5,684	$110.01	22,502	No	4	S	Indirect	By LCA
Common Stock	Disposition	2015-03-19	67	$111.06	22,435	No	4	S	Indirect	By LCA
Common Stock	Disposition	2015-03-19	3,907	$113.92	18,528	No	4	S	Indirect	By LCA
Common Stock	Disposition	2015-03-19	44	$114.15	18,484	No	4	S	Indirect	By LCA
Common Stock	Disposition	2015-03-19	123	$116.05	18,361	No	4	S	Indirect	By LCA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By LVP
No	4	S	Indirect	By LVP
No	4	S	Indirect	By LVP
No	4	S	Indirect	By LVP
No	4	S	Indirect	By LVP
No	4	S	Indirect	By LCA
No	4	S	Indirect	By LCA
No	4	S	Indirect	By LCA
No	4	S	Indirect	By LCA
No	4	S	Indirect	By LCA

Footnotes

Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $110.00 to $110.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $111.00 to $111.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $113.03 to $114.01. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $114.03 to $114.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $115.405 to $116.305. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $110.00 to $110.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $111.00 to $111.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $113.03 to $114.01. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $114.03 to $114.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of Common Stock of the Issuer executed in multiple transactions at prices ranging from $115.405 to $116.305. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Mr. Enright is a managing member of Longitude Capital Partners, LLC ("Longitude Capital"). Longitude Capital, as the general partner of each of Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Associates, L.P. ("LCA"), has the power to vote and dispose of securities held by each of them. As such, Mr. Enright may be deemed to beneficially own the shares held by LVP and LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of his pecuniary interest therein.